Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Clinical trial NCT03793517 · RECRUITING

Trial details

NCT number: NCT03793517
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stem Cell Transplant Complications Leukemia, Myeloid, Acute Leukemia Relapse

Start date: 2018-09-01
Primary completion: 2023-10-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.